Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by HighteawithIntrepidon Nov 15, 2017 12:30pm
372 Views
Post# 26968986

Show me vs trust me

Show me vs trust meOnce upon a time the market was led to believe that we
would have an FDA yes in April. It is now days away from 
December and PL is saying any day now. So my guess is
we get our yes mid December but the April 2018 yes is likely 
going to be August and another 40 million more burn then you 
believers think. Time will tell the tale. I can’t wait to see how the 
lads report the SRAM money for Income Tax purposes.
Sorry to much time on my hands watching the paint dry.
 The market will respond to ticked boxes not PL’ speeches.
Prometic lost its trust me premium. Yes this was a short attack but 
if the balance sheet had more cash and PL hadn’t been so over 
optomistic we wouldn’t have been vulnerable so that is on PL’s head.
Got a guess for the day we get the next FDA yes?
Bullboard Posts